Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2021-10-18 00:00:00 ET · period of report 2021-10-15 · accession 0001235802-21-000129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-18 | 2021-10-15 | XTNT | Browne Sean E | Pres, CEO, Dir | F - Tax | $1.11 | -160.2K | 1.64M | -9% | -$177.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.000001 par value | 2021-10-15 | F | D | 160,219 | $1.11 | 1,637,684 | D | — | — | (F1) Includes 197,426 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 1,101,644 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan. |